antigen-specific immunosuppressant (Myelin Repair Foundation)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantigen-specific immunosuppressant (Myelin Repair Foundation)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideCell and gene therapy > Cell therapy
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMyelin Repair Foundation
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A